DIABETES AND OBESITY BURDEN AND IMPROVEMENTS IN CARDIOMETABOLIC PARAMETERS IN PATIENTS WITH PSORIASIS OR PSORIATIC ARTHRITIS RECEIVING APREMILAST IN A REAL-WORLD SETTING
Published: 26 February 2024| Version 1 | DOI: 10.17632/zy52nd6c3w.1
Contributors:
Cristi Cavanaugh, , , , , , Description
Mendeley Supplemental Materials for Cristi Cavanaugh et al. DIABETES AND OBESITY BURDEN AND IMPROVEMENTS IN CARDIOMETABOLIC PARAMETERS IN PATIENTS WITH PSORIASIS OR PSORIATIC ARTHRITIS RECEIVING APREMILAST IN A REAL-WORLD SETTING. JAAD International. 2024.
Files
Institutions
Amgen Inc, OM1 Inc
Categories
Diabetes, Obesity, Psoriatic Arthritis, Psoriasis, Body Mass Index
Funding
Amgen